Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Mariangela Lecciso"'
Autor:
Darina Ocadlikova, Mariangela Lecciso, Javier Martin Broto, Katia Scotlandi, Michele Cavo, Antonio Curti, Emanuela Palmerini
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundHigh-grade sarcomas are a heterogeneous group of aggressive tumors arising in bone and soft tissues. After relapse, treatment options are limited. The multi-targeted receptor tyrosine kinase inhibitors (TKIs) sunitinib and inhibitor of PD-1
Externí odkaz:
https://doaj.org/article/f47503fa1f334b9dbe83c6daf7a0ec6b
Autor:
Sara Trabanelli, Mathieu F. Chevalier, Amaia Martinez-Usatorre, Alejandra Gomez-Cadena, Bérengère Salomé, Mariangela Lecciso, Valentina Salvestrini, Grégory Verdeil, Julien Racle, Cristina Papayannidis, Hideaki Morita, Irene Pizzitola, Camille Grandclément, Perrine Bohner, Elena Bruni, Mukul Girotra, Rani Pallavi, Paolo Falvo, Elisabeth Oppliger Leibundgut, Gabriela M. Baerlocher, Carmelo Carlo-Stella, Daniela Taurino, Armando Santoro, Orietta Spinelli, Alessandro Rambaldi, Emanuela Giarin, Giuseppe Basso, Cristina Tresoldi, Fabio Ciceri, David Gfeller, Cezmi A. Akdis, Luca Mazzarella, Saverio Minucci, Pier Giuseppe Pelicci, Emanuela Marcenaro, Andrew N. J. McKenzie, Dominique Vanhecke, George Coukos, Domenico Mavilio, Antonio Curti, Laurent Derré, Camilla Jandus
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-14 (2017)
Group 2 innate lymphoid cells (ILC2s) modulate inflammatory and allergic responses, but their function in cancer immunity is still unclear. Here the authors show that, in acute promyelocytic leukaemia, tumour-activated ILC2s secrete IL-13 to induce m
Externí odkaz:
https://doaj.org/article/acd6edf30f5b42e78199d6bb93f923c9
Autor:
Darina Ocadlikova, Mariangela Lecciso, Alessandro Isidori, Federica Loscocco, Giuseppe Visani, Sergio Amadori, Michele Cavo, Antonio Curti
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
In solid tumors and hematological malignancies, including acute myeloid leukemia, some chemotherapeutic agents, such as anthracyclines, have proven to activate an immune response via dendritic cell-based cross-priming of anti-tumor T lymphocytes. Thi
Externí odkaz:
https://doaj.org/article/ded27863e45a4408a047b44950893c70
Autor:
Mariangela Lecciso, Darina Ocadlikova, Sabina Sangaletti, Sara Trabanelli, Elena De Marchi, Elisa Orioli, Anna Pegoraro, Paola Portararo, Camilla Jandus, Andrea Bontadini, Annarita Redavid, Valentina Salvestrini, Pedro Romero, Mario P. Colombo, Francesco Di Virgilio, Michele Cavo, Elena Adinolfi, Antonio Curti
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Chemotherapy-induced immunogenic cell death can favor dendritic cell (DC) cross-priming of tumor-associated antigens for T cell activation thanks to the release of damage-associated molecular patterns, including ATP. Here, we tested the hypothesis th
Externí odkaz:
https://doaj.org/article/f87ab0dd0a8f4f79b935f68a291299ac
Autor:
Sarah Parisi, Mariangela Lecciso, Darina Ocadlikova, Valentina Salvestrini, Marilena Ciciarello, Dorian Forte, Giulia Corradi, Michele Cavo, Antonio Curti
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Natural killer (NK) cells are circulating CD3− lymphocytes, which express CD56 or CD16 and an array of inhibitory receptors, called killer-immunoglobulin-like receptors (KIRs). Alloreactive KIR-ligand mismatched NK cells crucially mediate the innat
Externí odkaz:
https://doaj.org/article/846b7fa25af345f8bc9060f8636e07ce
Autor:
Sara Trabanelli, Antonio Curti, Mariangela Lecciso, Bérengère Salomé, Carsten Riether, Adrian Ochsenbein, Pedro Romero, Camilla Jandus
Publikováno v:
Haematologica, Vol 100, Iss 7 (2015)
Externí odkaz:
https://doaj.org/article/c3203a567c7746dcb93159d23d32d3e8
Autor:
Sara Trabanelli, Mariangela Lecciso, Valentina Salvestrini, Michele Cavo, Darina Očadlíková, Roberto M. Lemoli, Antonio Curti
Publikováno v:
Journal of Immunology Research, Vol 2015 (2015)
In the last years, dendritic cells (DC) have been evaluated for antitumor vaccination. Although DC-based vaccines have raised great expectations, their clinical translation has been largely disappointing. For these results, several explanations
Externí odkaz:
https://doaj.org/article/591510b08fbf4adcbae8a69e8031843d
Autor:
Roberto M. Lemoli, Andrea Velardi, Michele Cavo, Russell E. Lewis, Francesca Bonifazi, Giuseppe Bandini, Giovanni Martinelli, Cristina Papayannidis, Elena Urbani, Fiorenza Fruet, Valeria Giudice, Mariangela Lecciso, Darina Ocadlikova, Sara Trabanelli, Simonetta Rizzi, Maria Rosa Motta, Elisa Dan, Andrea Bontadini, Sarah Parisi, Loredana Ruggeri, Antonio Curti
Figure S1. Hematologic recovery after NK cell infusion in all treated patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce1c2827e2bc2cf83883c2b2b09af190
https://doi.org/10.1158/1078-0432.22461381
https://doi.org/10.1158/1078-0432.22461381
Autor:
Roberto M. Lemoli, Andrea Velardi, Michele Cavo, Russell E. Lewis, Francesca Bonifazi, Giuseppe Bandini, Giovanni Martinelli, Cristina Papayannidis, Elena Urbani, Fiorenza Fruet, Valeria Giudice, Mariangela Lecciso, Darina Ocadlikova, Sara Trabanelli, Simonetta Rizzi, Maria Rosa Motta, Elisa Dan, Andrea Bontadini, Sarah Parisi, Loredana Ruggeri, Antonio Curti
Table S1. Percentage and absolute number of alloreactive NK cells in responders (A) and non-responders (B) Table S2. Description of cell processing results in responders (A) and non-responders (B)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d14951478d2833e389a6945b9feb28d
https://doi.org/10.1158/1078-0432.22461369
https://doi.org/10.1158/1078-0432.22461369
Autor:
Roberto M. Lemoli, Andrea Velardi, Michele Cavo, Russell E. Lewis, Francesca Bonifazi, Giuseppe Bandini, Giovanni Martinelli, Cristina Papayannidis, Elena Urbani, Fiorenza Fruet, Valeria Giudice, Mariangela Lecciso, Darina Ocadlikova, Sara Trabanelli, Simonetta Rizzi, Maria Rosa Motta, Elisa Dan, Andrea Bontadini, Sarah Parisi, Loredana Ruggeri, Antonio Curti
Purpose: In acute myeloid leukemia (AML), alloreactive natural killer (NK) cells are crucial mediators of immune responses after haploidentical stem cell transplantation. Allogeneic NK cell infusions have been adoptively transferred with promising cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b82fdf771242d602eb7d01431277d6b
https://doi.org/10.1158/1078-0432.c.6524781.v1
https://doi.org/10.1158/1078-0432.c.6524781.v1